A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer

Authors

  • Daniel Morgensztern Department of Medicine, Division of Medical Oncology, Washington University School of Medicine and Alvin Siteman Cancer Center, St. Louis, Missouri, USA
  • Michael C. Perry Ellis Fischel Cancer Center, Columbia, Missouri, USA
  • Ramaswamy Govindan Department of Medicine, Division of Medical Oncology, Washington University School of Medicine and Alvin Siteman Cancer Center, St. Louis, Missouri, USA

DOI:

https://doi.org/10.1080/02841860701418853

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

2008-01-01

How to Cite

Morgensztern, D. ., Perry, M. C. ., & Govindan, R. . (2008). A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancer. Acta Oncologica, 47(1), 152–153. https://doi.org/10.1080/02841860701418853

Issue

Vol. 47 No. 1 (2008): Acta Oncologica

Section

Articles